An International Phase 2-3, Stratified, Randomized, Open-Label, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.

Trial Profile

An International Phase 2-3, Stratified, Randomized, Open-Label, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs Enoxaparin sodium; Heparin
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms STEEPLE
  • Sponsors Aventis Pharmaceuticals; Sanofi
  • Most Recent Events

    • 30 Aug 2010 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
    • 05 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top